Methods and compositions for predicting response to eribulin
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 2, 2017
Grant Date -
Aug 21, 2014
app pub date -
Mar 16, 2012
filing date -
Mar 18, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention provides methods for predicting the efficacy of eribulin, an analog thereof, or a pharmaceutically acceptable salt thereof (e.g., eribulin mesylate), in the treatment of a subject suffering from breast cancer by determining the level of particular biomarkers in a sample derived from the subject.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully